- Ongoing, recruitingHuman Pharmacology (Phase I)- First administration to humans
A randomized first-in-human, Phase 1, single-center, observer-blind, active-controlled 3-arm study to evaluate the safety, tolerability, and immunogenicity of one single administration of TETRALITE, a novel adjuvanted influenza vaccine, in healthy participants aged 18 to 50 years
This study is testing a new flu vaccine called TETRALITE in healthy adults. Researchers want to see if it's safe, how well people tolerate it, and how strongly it helps the body fight off the flu compared to an existing flu vaccine.
For: InfluenzaBelgium - Ongoing, recruitingTherapeutic use (Phase IV)
Optimizing the time of day of influenza vaccine administration in adults aged 60-85 years: A randomized controlled trial
This study is looking at the best time of day for people aged 60-85 to have their flu jab. We want to see if getting the vaccine at a certain time helps your body create more protection against the flu virus.
For: InfluenzaNetherlands